StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Truist Securities Reinstates Pacira Pharmaceuticals (PCRX) at Buy
August 17, 2026 6:14 AM
Truist Securities analyst Anish Nikhanj reinstates coverage on Pacira Pharmaceuticals ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
New Coverage